1. A5.10 Increases in serum cholesterol with baricitinib treatment are associated with favourable changes in apolipoprotein content and with improvement in DAS28-CRP in patients with rheumatoid arthritis. (13th February 2015) Authors: Kremer, J; Genovese, MC; Keystone, E; Taylor, P; Zuckerman, SH; Schlichting, DE; Nantz, E; Beattie, SD; Macias, WL Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 1 Page Start: A51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A7.16 Characterisation of changes in lymphocyte subsets in baricitinib-treated patients with rheumatoid arthritis in two phase 3 studies. (24th February 2016) Authors: Emery, P; McInnes, I; Genovese, MC; Smolen, JS; Kremer, J; Dougados, M; Schlichting, DE; Rooney, T; Issa, M; de Bono, S; Macias, WL; Rogai, V; Zuckerman, SH; Taylor, PC Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 1 Page Start: A62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A7.17 Effects of baricitinib on multibiomarker disease activity scores and their components in a phase 2b study in moderate-to-severe rheumatoid arthritis patients. (24th February 2016) Authors: Taylor, PC; Genovese, MC; Keystone, E; Weinblatt, M; Rancourt, J; Nantz, E; Schlichting, DE; Zuckerman, SH; Macias, WL Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 1 Page Start: A62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A8.5 Baricitinib effects on serum cholesterol and circulating lipid particles in a phase 2B study in patients with rheumatoid arthritis. (13th February 2015) Authors: Kremer, J; Genovese, MC; Keystone, E; Taylor, P; Zuckerman, SH; Schlichting, DE; Beattie, SD; Macias, WL Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 1 Page Start: A83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P059 Ex vivo comparison of baricitinib, upadacitinib, filgotinib and tofacitinib for cytokine signalling in human leukocyte subpopulations. (21st February 2018) Authors: McInnes, IB; Higgs, R; Lee, J; Macias, WL; Na, S; Ortmann, RA; Rocha, G; Wehrman, T; Zhang, X; Zuckerman, SH; Taylor, PC; Perrier, C Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 1 Page Start: A38 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P092 Microarray pathway analysis comparing baricitinib and adalimumab in moderate to severe rheumatoid arthritis from a phase 3 study. (21st February 2018) Authors: Emery, P; Taylor, PC; Weinblatt, ME; Tanaka, Y; Keystone, EC; Dow, ER; Higgs, R; Macias, WL; Rocha, G; Rooney, TP; Schlichting, DE; Zuckerman, SH; McInnes, IB; Holzkaemper, T Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 1 Page Start: A52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗